Caligan Partners LP - 31 Dec 2024 SCHEDULE 13G Report for Verrica Pharmaceuticals Inc. Common stock, $0.0001 par value per share (VRCA)

Filing Manager: Caligan Partners LP
Reporting Manager: Caligan Partners LP
Security: Verrica Pharmaceuticals Inc. Common stock, $0.0001 par value per share
Symbol: VRCA
Shares outstanding: 158,725,255 shares
Disclosed Ownership: 15,856,653 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 12 Feb 2025, 16:05:38 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Caligan Partners LP	10%	15,856,653	0	15,856,653	/s/ David Johnson	David Johnson, Managing Partner
David Johnson	10%	15,856,653	0	15,856,653	/s/ David Johnson	David Johnson, Individually